|
|
||||||||
Journal of Lipid Research, Vol 25, 175-184, Copyright © 1984 by Lipid Research, Inc.
A Hara, N Kitazawa and T Taketomi
Glycosphingolipids from brain, liver, and spleen of a patient with
mucopolysaccharidosis type III B were quantitatively analyzed. Neutral
glycosphingolipids containing glucosylceramide, lactosylceramide,
globotriaosylceramide, globotetraosylceramide, and gangliotriaosylceramide
were increased in the brain, while the contents of galactosylceramide and
galactosylceramide I3-sulfate were decreased. The total ganglioside levels
were low in the grey matter (522 micrograms N-acetylneuraminic acid/g) and
high in the white matter (342 micrograms N-acetylneuraminic acid/g), when
compared with the normal values (744-918 micrograms/g in grey matter and
80-180 micrograms/g in white matter). The ganglioside compositions were
characterized by a high proportion of
II3-N-acetylneuraminosylgangliotriaosylceramide (GM2),
II3-N-acetylneuraminosyllactosylceramide (GM3), and II3-(N-
acetylneuraminosyl)2lactosylceramide (GD3). An unusual band of protein in
place of an ordinary band of Wolfgram protein was detected as a major band
by sodium dodecylsulfate-polyacrylamide gel electrophoresis. The low levels
of 4-eicosasphingenine in the brain gangliosides indicated that the
disturbance of the sphingolipid metabolism already began at age 3 at the
latest and that the brain remained immature. These abnormal
glycosphingolipids and protein as well as the accumulation of heparan
sulfate explain in part the severe progressive mental retardation which is
most characteristic of the mucopolysaccharidosis III B. Abnormalities of
glycosphingolipids in the liver and spleen are also found.
ARTICLES
Abnormalities of glycosphingolipids in mucopolysaccharidosis type III B
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Ohmi, D. S. Greenberg, K. S. Rajavel, S. Ryazantsev, H. H. Li, and E. F. Neufeld Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB PNAS, February 18, 2003; 100(4): 1902 - 1907. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Taketomi, E. Sugiyama, K.-i. Uemura, A. Hara, H. Hidaka, M. Tozuka, T. Nakabayashi, and T. Katsuyama Confirmation of minor components of less polar neutral and acidic glycolipids in monkey brain tissue J. Lipid Res., May 1, 2001; 42(5): 873 - 885. [Abstract] [Full Text] |
||||
![]() |
H. H. Li, W.-H. Yu, N. Rozengurt, H.-Z. Zhao, K. M. Lyons, S. Anagnostaras, M. S. Fanselow, K. Suzuki, M. T. Vanier, and E. F. Neufeld Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha -N-acetylglucosaminidase PNAS, December 7, 1999; 96(25): 14505 - 14510. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |